151 related articles for article (PubMed ID: 20036958)
1. Biological and clinical markers in colorectal cancer: state of the art.
Cappellani A; Di Vita M; Zanghi A; Veroux P; Cavallaro A; Lo Menzo E; Cacopardo B; Canzonieri V; Murabito P; Tirelli U; Berretta M
Front Biosci (Schol Ed); 2010 Jan; 2(2):422-31. PubMed ID: 20036958
[TBL] [Abstract][Full Text] [Related]
2. Serum and tissue markers in colorectal cancer: State of art.
Berretta M; Alessandrini L; De Divitiis C; Nasti G; Lleshi A; Di Francia R; Facchini G; Cavaliere C; Buonerba C; Canzonieri V
Crit Rev Oncol Hematol; 2017 Mar; 111():103-116. PubMed ID: 28259285
[TBL] [Abstract][Full Text] [Related]
3. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA dysregulation in colorectal cancer: a clinical perspective.
Dong Y; Wu WK; Wu CW; Sung JJ; Yu J; Ng SS
Br J Cancer; 2011 Mar; 104(6):893-8. PubMed ID: 21364594
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates.
Mahasneh A; Al-Shaheri F; Jamal E
Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769
[TBL] [Abstract][Full Text] [Related]
8. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
[TBL] [Abstract][Full Text] [Related]
9. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
10. Novel Diagnostic Biomarkers in Colorectal Cancer.
Zygulska AL; Pierzchalski P
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055034
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive molecular biomarkers for the detection of colorectal cancer.
Kim HJ; Yu MH; Kim H; Byun J; Lee C
BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
[TBL] [Abstract][Full Text] [Related]
14. Multi-Target Stool DNA Test: Is the Future Here?
Sweetser S; Ahlquist DA
Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
[TBL] [Abstract][Full Text] [Related]
15. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
16. Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer.
Zhang Y; Wang Y; Zhang B; Li P; Zhao Y
Biomed Pharmacother; 2023 Jul; 163():114786. PubMed ID: 37119736
[TBL] [Abstract][Full Text] [Related]
17. Tests and investigations for colorectal cancer screening.
Carroll MR; Seaman HE; Halloran SP
Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
[TBL] [Abstract][Full Text] [Related]
18. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
Graziano F; Catalano V; Baldelli AM; Cascinu S
Expert Rev Anticancer Ther; 2001 Aug; 1(2):247-57. PubMed ID: 12113030
[TBL] [Abstract][Full Text] [Related]
19. Faecal occult blood testing for colorectal cancer screening: the past or the future.
Benton SC; Seaman HE; Halloran SP
Curr Gastroenterol Rep; 2015 Feb; 17(2):428. PubMed ID: 25673567
[TBL] [Abstract][Full Text] [Related]
20. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
